Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription Articles published in J Clin Invest Retrieve available abstracts of 51 articles: HTML format

Single Articles

October 2026
1. JAMIL R, Huibner S, Yang P, Nnamutete J, et al
   Impact of sexual debut on urethral immunology and microbiome in adolescent males from Rakai, Uganda.
   J Clin Invest. 2026 Oct 6:e208629. doi: 10.1172/JCI208629.
   PubMed     Abstract available
   
   
   August 2026
2. JALALI S, Natesampillai S, Nie Z, Zhang Y, et al
   TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo.
   J Clin Invest. 2026;136:e194449.
   PubMed     Abstract available
   
   
   July 2026
3. MOYSI E, Sharma AA, O'Dell S, Georgakis S, et al
   A favorable follicular helper CD4 T cell programming characterizes neutralization activity in chronic HIV infection.
   J Clin Invest. 2026 Jul 14:e192575. doi: 10.1172/JCI192575.
   PubMed     Abstract available
   
   
   June 2026
4. HOTCHKISS RS, Monneret G
   Host-directed immune therapies: a second front in the battle against sepsis.
   J Clin Invest. 2026;136:e204736.
   PubMed     Abstract available
   
   
   May 2026
5. GAY CL, Xu Y, Weideman AMK, Shaw FR, et al
   MVA.tHIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy.
   J Clin Invest. 2026 May 5:e193547. doi: 10.1172/JCI193547.
   PubMed     Abstract available
   
   
   
6. NIDEFFER J, Bach F, Strubbe S, Lopez L, et al
   CXCR6+CD127- Tr1 cells balance immunity and persistence in Plasmodium falciparum infection.
   J Clin Invest. 2026 May 5:e200628. doi: 10.1172/JCI200628.
   PubMed     Abstract available
   
   
   
7. FILIPPIDIS P, Farhadian SF
   Smoldering in the sanctuary: HIV-associated brain injury in the ART era.
   J Clin Invest. 2026;136:e204831.
   PubMed     Abstract available
   
   
   April 2026
8. CASCINO K, Liechti T, Seaberg EC, Stevens KE, et al
   HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohort.
   J Clin Invest. 2026 Apr 7:e203138. doi: 10.1172/JCI203138.
   PubMed     Abstract available
   
   
   
9. MASSANELLA M, Dufour C, Pagliuzza A, Lemieux A, et al
   Rapid and profound decay of inducible and intact HIV genomes in early treated Thai children.
   J Clin Invest. 2026 Apr 2:e198054. doi: 10.1172/JCI198054.
   PubMed     Abstract available
   
   
   March 2026
10. PACHE L, Bui JK, Klouser LM, Fennessey CM, et al
    Smac mimetic combined with eCD4-Ig reverses latency without reducing SHIV reservoirs in rhesus macaques.
    J Clin Invest. 2026;136:e187961.
    PubMed     Abstract available
    
    
    February 2026
11. PAL PB, Elizaldi SR, Diniz GB, Rai RP, et al
    alpha4 integrin blockade impairs CD8 T cell neuroimmune surveillance following SIV infection.
    J Clin Invest. 2026 Feb 24:e198730. doi: 10.1172/JCI198730.
    PubMed     Abstract available
    
    
    
12. BLAZKOVA J, Kennedy BD, Justement JS, Shi V, et al
    Characterization of elite controllers with undetectable intact HIV DNA reservoir.
    J Clin Invest. 2026 Feb 17:e202577. doi: 10.1172/JCI202577.
    PubMed    
    
    
    
13. NIESAR A, Lancien M, Hong S, Naasz C, et al
    Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young children.
    J Clin Invest. 2026;136:e193912.
    PubMed     Abstract available
    
    
    
14. ELWY A, Abdelrahman H, Specht J, Ewert GM, et al
    Type I IFN-dependent FcgammaRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infections.
    J Clin Invest. 2026;136:e192371.
    PubMed     Abstract available
    
    
    
15. KIOKO M, Mwangi S, Fwambah L, Hassan AS, et al
    Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort.
    J Clin Invest. 2026 Feb 12:e195172. doi: 10.1172/JCI195172.
    PubMed     Abstract available
    
    
    January 2026
16. OMANGE WR, Varco-Merth BD, Fadeyi O, Marenco A, et al
    Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.
    J Clin Invest. 2026 Jan 29:e198294. doi: 10.1172/JCI198294.
    PubMed     Abstract available
    
    
    December 2025
17. PETERSON JJ, Chandel S, James K, Bennett ES, et al
    Single cell characterization of the gastrointestinal HIV reservoir reveals heterogeneous cellular phenotypes.
    J Clin Invest. 2025 Dec 23:e196536. doi: 10.1172/JCI196536.
    PubMed     Abstract available
    
    
    
18. ABELMAN RA, Schnittman SR, Faraj Murad N, Olshen A, et al
    Age modifies the association between sex and the plasma inflammatory proteome in treated HIV.
    J Clin Invest. 2025 Dec 9:e196869. doi: 10.1172/JCI196869.
    PubMed     Abstract available
    
    
    November 2025
19. DONALDSON A, Druker MR, Monaco MC, Stack EH, et al
    Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells.
    J Clin Invest. 2025 Nov 25:e195764. doi: 10.1172/JCI195764.
    PubMed     Abstract available
    
    
    October 2025
20. DRAGONI F, Sop J, Gurumurthy I, Beckey TP, et al
    Selective targeting of HIV infected clones by cognate peptide stimulation and antiproliferative drugs.
    J Clin Invest. 2025 Oct 21:e197266. doi: 10.1172/JCI197266.
    PubMed     Abstract available
    
    
    
21. ARCHIN NM
    A die is cast: autologous neutralizing antibody resistance shapes the HIV reservoir during uninterrupted ART.
    J Clin Invest. 2025;135:e198353.
    PubMed     Abstract available
    
    
    September 2025
22. KOLOSSVARY M, Sereti I, Zanni MV, Fichtenbaum CJ, et al
    Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV.
    J Clin Invest. 2025 Sep 9:e196021. doi: 10.1172/JCI196021.
    PubMed     Abstract available
    
    
    August 2025
23. OMOLE TE, McKinnon LR
    Integrin alpha4beta7 as a predictor of HIV acquisition: one thread in a complex tapestry.
    J Clin Invest. 2025;135:e195258.
    PubMed     Abstract available
    
    
    July 2025
24. MCMYN NF, Varriale J, Wu HWS, Hariharan V, et al
    Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies.
    J Clin Invest. 2025 Jul 29:e194081. doi: 10.1172/JCI194081.
    PubMed     Abstract available
    
    
    
25. JASINSKA AJ, Sivanandham R, Sivanandham S, Xu C, et al
    Pathogenic SIV infection is associated with acceleration of epigenetic age in rhesus macaques.
    J Clin Invest. 2025;135:e189574.
    PubMed     Abstract available
    
    
    June 2025
26. RAMASWAMY S, Akiyama H, Berrigan J, Quinones-Molina AA, et al
    The macrophage-intrinsic MDA5-IRF5 axis drives HIV-1 intron-containing RNA-induced inflammatory responses.
    J Clin Invest. 2025 Jun 10:e187663. doi: 10.1172/JCI187663.
    PubMed     Abstract available
    
    
    
27. DESAI SS, Salahuddin S, Yusuf R, Ranjan K, et al
    Tumor microenvironment of non-small cell lung cancer impairs immune cell function among people with HIV.
    J Clin Invest. 2025 Jun 3:e177310. doi: 10.1172/JCI177310.
    PubMed     Abstract available
    
    
    May 2025
28. MACHMACH K, N'guessan KF, Farmer R, Godbole S, et al
    NK cell activation and CD4 T cell alpha4beta7 expression are associated with susceptibility to HIV-1.
    J Clin Invest. 2025 May 8:e187992. doi: 10.1172/JCI187992.
    PubMed     Abstract available
    
    
    April 2025
29. IMAMICHI H, Natarajan V, Scrimieri F, Smith M, et al
    Widespread distribution of transcriptionally active, clonally expanded, HIV-1 proviruses despite suppressive antiretroviral therapy.
    J Clin Invest. 2025 Apr 22:e190824. doi: 10.1172/JCI190824.
    PubMed     Abstract available
    
    
    
30. PAL PB, Iyer SS
    Transient pain and long-term gain: adjuvant dose directs immune memory.
    J Clin Invest. 2025;135:e190524.
    PubMed     Abstract available
    
    
    
31. VIOLARI A, Otwombe K, Hahn W, Chen S, et al
    Safety and implementation of phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.
    J Clin Invest. 2025 Apr 3:e186927. doi: 10.1172/JCI186927.
    PubMed     Abstract available
    
    
    
32. SETIABUDIAWAN TP, Hill PC, DiNardo AR, van Crevel R, et al
    Insights into protection against Mycobacterium tuberculosis infection: time to officially confirm another phenotype?
    J Clin Invest. 2025;135:e191423.
    PubMed     Abstract available
    
    
    March 2025
33. MACLEAN F, Tsegaye AT, Graham JB, Swarts JL, et al
    Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract.
    J Clin Invest. 2025 Mar 25:e184609. doi: 10.1172/JCI184609.
    PubMed     Abstract available
    
    
    
34. KATUSIIME MG, Neer V, Guo S, Patro SC, et al
    Divergent populations of HIV-infected naive and memory CD4+ T-cell clones in children on antiretroviral therapy.
    J Clin Invest. 2025 Mar 6:e188533. doi: 10.1172/JCI188533.
    PubMed     Abstract available
    
    
    
35. RAMEZANI-RAD P, Marina-Zarate E, Maiorino L, Myers A, et al
    The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in non-human primates.
    J Clin Invest. 2025 Mar 4:e185292. doi: 10.1172/JCI185292.
    PubMed     Abstract available
    
    
    February 2025
36. MU W, Tomer S, Harding J, Kedia N, et al
    Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo.
    J Clin Invest. 2025 Feb 11:e185489. doi: 10.1172/JCI185489.
    PubMed     Abstract available
    
    
    January 2025
37. TADDESE M, Grudda T, Belluccini G, Anderson M, et al
    Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment.
    J Clin Invest. 2025 Jan 30:e184243. doi: 10.1172/JCI184243.
    PubMed     Abstract available
    
    
    
38. DALLMANN-SAUER M, Fava VM, Malherbe ST, MacDonald CE, et al
    Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli.
    J Clin Invest. 2025 Jan 21:e188016. doi: 10.1172/JCI188016.
    PubMed     Abstract available
    
    
    December 2024
39. LEE MJ, Yeon JH, Lee J, Kang YH, et al
    Senescence of endothelial cells increases susceptibility to Kaposi's sarcoma-associated herpesvirus infection via CD109-mediated viral entry.
    J Clin Invest. 2024 Dec 12:e183561. doi: 10.1172/JCI183561.
    PubMed     Abstract available
    
    
    November 2024
40. GONZALEZ-NAVARRO I, Urrea V, Galvez C, Garcia-Guerrero MDC, et al
    Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.
    J Clin Invest. 2024 Nov 29:e183952. doi: 10.1172/JCI183952.
    PubMed     Abstract available
    
    
    October 2024
41. DURAND CM, Redd AD
    HOPE springs eternal: lack of HIV superinfection in HIV Organ Policy Equity Act kidney transplants.
    J Clin Invest. 2024;134:e184326.
    PubMed     Abstract available
    
    
    
42. MANNING MR, Blazkova J, Justement JS, Shi V, et al
    Timing of antiretroviral therapy initiation affects intact HIV reservoirs following analytical treatment interruption.
    J Clin Invest. 2024;134:e181632.
    PubMed    
    
    
    
43. KINCER LP, Dravid A, Trunfio M, Calcagno A, et al
    Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS T cells and inflammation.
    J Clin Invest. 2024;134:e176358.
    PubMed     Abstract available
    
    
    September 2024
44. MIHEALSICK E, Word A, Scully EP
    The impact of sex on HIV immunopathogenesis and therapeutic interventions.
    J Clin Invest. 2024;134:e180075.
    PubMed     Abstract available
    
    
    
45. TRAVIESO T, Stadtler H, Alavian N, Gao F, et al
    Longitudinal analysis of viral dynamics in HIV+ to HIV+ HOPE Act kidney-transplant recipients.
    J Clin Invest. 2024 Sep 10:e181560. doi: 10.1172/JCI181560.
    PubMed     Abstract available
    
    
    July 2024
46. KLOTMAN ME, Haynes BF
    The other pandemic: lessons from 40 years of HIV research.
    J Clin Invest. 2024;134:e183039.
    PubMed    
    
    
    June 2024
47. JOY J, Gervassi AL, Chen L, Kirshenbaum B, et al
    Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation.
    J Clin Invest. 2024 Jun 4:e159569. doi: 10.1172/JCI159569.
    PubMed     Abstract available
    
    
    May 2024
48. TEBAS P, Jadlowsky JK, Shaw PA, Tian L, et al
    CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
    J Clin Invest. 2024;134:e181576.
    PubMed    
    
    
    April 2024
49. WHITEHILL GD, Joy J, Marino FE, Krause RJ, et al
    Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1.
    J Clin Invest. 2024 Apr 23:e176673. doi: 10.1172/JCI176673.
    PubMed     Abstract available
    
    
    
50. EICHHOLZ K, Fukazawa Y, Peterson CW, Haeseleer F, et al
    Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.
    J Clin Invest. 2024;134:e169309.
    PubMed     Abstract available
    
    
    March 2024
51. ELIZALDI SR, Hawes CE, Verma A, Shaan Lakshmanappa Y, et al
    Chronic SIV-induced neuroinflammation disrupts CCR7+CD4+ T cell immunosurveillance in the rhesus macaque brain.
    J Clin Invest. 2024 Mar 12:e175332. doi: 10.1172/JCI175332.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum